Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|17|5|488-494

ISSN： 1389-4501

Source： Current Drug Targets, Vol.17, Iss.5, 2016-04, pp. : 488-494

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Development of Hypoxia Selective Cytotoxins for Cancer Treatment: An Update

By  

Medicinal Chemistry, Vol. 2, Iss. 3, 2006-01 ,pp. : 315-327

Bentham Science Publishers

Access to resources Recommend Favorite

Nanoparticulate delivery of LHRH analogue for the treatment of prostate cancer

By Tomar Priti  

Pharmaceutical Development and Technology, Vol. 18, Iss. 3, 2013-06 ,pp. : 645-652

Informa Healthcare

Access to resources Recommend Favorite

AEZS-108: a targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors

By Engel Joerg   Emons Guenter   Pinski Jacek   Schally Andrew V  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 6, 2012-06 ,pp. : 891-899

Informa Healthcare

Access to resources Recommend Favorite

Targeting HER Receptors in Cancer

By  

Current Pharmaceutical Design, Vol. 19, Iss. 5, 2013-02 ,pp. : 808-817

Bentham Science Publishers

Access to resources Recommend Favorite

Peptide and Non-peptide Antagonists Targeting Endothelin Receptors in Physiology and Pathology

By  

Current Pharmaceutical Design, Vol. 17, Iss. 25, 2011-08 ,pp. : 2613-2625

Bentham Science Publishers

Access to resources Recommend Favorite